Kalypsys, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Latest on Kalypsys, Inc.
[Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog .] Perhaps you’ll feast on corned beef, ca
Like many of its Big Pharma peers – particularly Pfizer Inc. and Bayer AG , Merck & Co. Inc. is jumping wholeheartedly into collaborations with its academic counterparts in hopes of getting
Aragon Pharmaceuticals (US), privately held small-molecule drug discovery company identifying medicines for the treatment of hormonally driven cancers, has appointed Dr Richard Heyman chief executive
While the venture capital community spent roughly the same in biopharma investments in 2006 as they did in 2005 (about $4.3 billion), they put considerably more money into mid-stage companies (Series